JPWO2020177819A5 - - Google Patents
Download PDFInfo
- Publication number
- JPWO2020177819A5 JPWO2020177819A5 JP2021547498A JP2021547498A JPWO2020177819A5 JP WO2020177819 A5 JPWO2020177819 A5 JP WO2020177819A5 JP 2021547498 A JP2021547498 A JP 2021547498A JP 2021547498 A JP2021547498 A JP 2021547498A JP WO2020177819 A5 JPWO2020177819 A5 JP WO2020177819A5
- Authority
- JP
- Japan
- Prior art keywords
- chewing gum
- gum composition
- layer
- composition according
- compressed chewing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229940112822 chewing gum Drugs 0.000 claims 35
- 235000015218 chewing gum Nutrition 0.000 claims 35
- 239000000203 mixture Substances 0.000 claims 33
- 229930003827 cannabinoid Natural products 0.000 claims 13
- 239000003557 cannabinoid Substances 0.000 claims 13
- 229940065144 cannabinoids Drugs 0.000 claims 12
- 239000002245 particle Substances 0.000 claims 11
- 239000004615 ingredient Substances 0.000 claims 4
- ZROLHBHDLIHEMS-HUUCEWRRSA-N (6ar,10ar)-6,6,9-trimethyl-3-propyl-6a,7,8,10a-tetrahydrobenzo[c]chromen-1-ol Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCC)=CC(O)=C3[C@@H]21 ZROLHBHDLIHEMS-HUUCEWRRSA-N 0.000 claims 2
- UCONUSSAWGCZMV-HZPDHXFCSA-N Delta(9)-tetrahydrocannabinolic acid Chemical compound C([C@H]1C(C)(C)O2)CC(C)=C[C@H]1C1=C2C=C(CCCCC)C(C(O)=O)=C1O UCONUSSAWGCZMV-HZPDHXFCSA-N 0.000 claims 2
- ZROLHBHDLIHEMS-UHFFFAOYSA-N Delta9 tetrahydrocannabivarin Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCC)=CC(O)=C3C21 ZROLHBHDLIHEMS-UHFFFAOYSA-N 0.000 claims 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 claims 2
- CYQFCXCEBYINGO-UHFFFAOYSA-N THC Natural products C1=C(C)CCC2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3C21 CYQFCXCEBYINGO-UHFFFAOYSA-N 0.000 claims 2
- QHMBSVQNZZTUGM-UHFFFAOYSA-N Trans-Cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-UHFFFAOYSA-N 0.000 claims 2
- QHMBSVQNZZTUGM-ZWKOTPCHSA-N cannabidiol Chemical compound OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 QHMBSVQNZZTUGM-ZWKOTPCHSA-N 0.000 claims 2
- 229950011318 cannabidiol Drugs 0.000 claims 2
- ZTGXAWYVTLUPDT-UHFFFAOYSA-N cannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1C1C(C(C)=C)CC=C(C)C1 ZTGXAWYVTLUPDT-UHFFFAOYSA-N 0.000 claims 2
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 claims 2
- PCXRACLQFPRCBB-ZWKOTPCHSA-N dihydrocannabidiol Natural products OC1=CC(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)C)CCC(C)=C1 PCXRACLQFPRCBB-ZWKOTPCHSA-N 0.000 claims 2
- 229960004242 dronabinol Drugs 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 235000000346 sugar Nutrition 0.000 claims 2
- 150000005846 sugar alcohols Chemical class 0.000 claims 2
- 150000008163 sugars Chemical class 0.000 claims 2
- NLHHRLWOUZZQLW-UHFFFAOYSA-N Acrylonitrile Chemical compound C=CC#N NLHHRLWOUZZQLW-UHFFFAOYSA-N 0.000 claims 1
- REOZWEGFPHTFEI-JKSUJKDBSA-N Cannabidivarin Chemical compound OC1=CC(CCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 REOZWEGFPHTFEI-JKSUJKDBSA-N 0.000 claims 1
- 208000027205 Congenital disease Diseases 0.000 claims 1
- 208000029767 Congenital, Hereditary, and Neonatal Diseases and Abnormalities Diseases 0.000 claims 1
- 208000001640 Fibromyalgia Diseases 0.000 claims 1
- 208000018522 Gastrointestinal disease Diseases 0.000 claims 1
- 206010061218 Inflammation Diseases 0.000 claims 1
- 208000022559 Inflammatory bowel disease Diseases 0.000 claims 1
- 206010028813 Nausea Diseases 0.000 claims 1
- 206010028980 Neoplasm Diseases 0.000 claims 1
- 208000012902 Nervous system disease Diseases 0.000 claims 1
- 208000025966 Neurological disease Diseases 0.000 claims 1
- 206010048685 Oral infection Diseases 0.000 claims 1
- 208000002193 Pain Diseases 0.000 claims 1
- 230000004596 appetite loss Effects 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 230000004888 barrier function Effects 0.000 claims 1
- 201000011510 cancer Diseases 0.000 claims 1
- WVOLTBSCXRRQFR-DLBZAZTESA-N cannabidiolic acid Chemical compound OC1=C(C(O)=O)C(CCCCC)=CC(O)=C1[C@H]1[C@H](C(C)=C)CCC(C)=C1 WVOLTBSCXRRQFR-DLBZAZTESA-N 0.000 claims 1
- 229920001577 copolymer Polymers 0.000 claims 1
- 206010012601 diabetes mellitus Diseases 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 208000019017 loss of appetite Diseases 0.000 claims 1
- 235000021266 loss of appetite Nutrition 0.000 claims 1
- 239000000463 material Substances 0.000 claims 1
- 230000008693 nausea Effects 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 208000020016 psychiatric disease Diseases 0.000 claims 1
- 201000002859 sleep apnea Diseases 0.000 claims 1
- 208000004371 toothache Diseases 0.000 claims 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US16/289,770 | 2019-03-01 | ||
| CA3035400A CA3035400C (en) | 2019-03-01 | 2019-03-01 | Tableted cannabinoid chewing gum with layered structure |
| US16/289,770 US10799450B2 (en) | 2019-03-01 | 2019-03-01 | Tableted cannabinoid chewing gum with layered structure |
| CA3,035,400 | 2019-03-01 | ||
| PCT/DK2019/050308 WO2020177819A1 (en) | 2019-03-01 | 2019-10-10 | Tableted cannabinoid chewing gum with layered structure |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| JP2022521711A JP2022521711A (ja) | 2022-04-12 |
| JPWO2020177819A5 true JPWO2020177819A5 (https=) | 2022-10-18 |
| JP2022521711A5 JP2022521711A5 (https=) | 2022-10-18 |
| JP7601779B2 JP7601779B2 (ja) | 2024-12-17 |
Family
ID=68617969
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547498A Active JP7601779B2 (ja) | 2019-03-01 | 2019-10-10 | 層状構造を有する打錠カンナビノイドチューインガム |
Country Status (9)
| Country | Link |
|---|---|
| EP (2) | EP3876744B1 (https=) |
| JP (1) | JP7601779B2 (https=) |
| CN (1) | CN113423279A (https=) |
| AU (1) | AU2019432306B2 (https=) |
| BR (1) | BR112021012489A2 (https=) |
| ES (1) | ES2970150T3 (https=) |
| MX (1) | MX2021008938A (https=) |
| WO (1) | WO2020177819A1 (https=) |
| ZA (1) | ZA202104509B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US12383591B2 (en) * | 2019-11-12 | 2025-08-12 | London Pharmaceuticals And Research Corporation | Chewing gum containing synergistic medicinal compounds |
| WO2024227046A2 (en) * | 2023-04-28 | 2024-10-31 | Whelpley Gordon Brittain Iii | Spray application of water-soluble actives to drinking vessels and other objects |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| LU71919A1 (https=) * | 1975-02-26 | 1977-01-06 | ||
| GB0216413D0 (en) * | 2002-07-15 | 2002-08-21 | Nestle Sa | Tabletted chewing gum sweet |
| EP1449525A1 (en) * | 2003-02-20 | 2004-08-25 | Cross Chem Llc | chewing gum in the form of multi-layer tablets |
| EP1554935A1 (en) * | 2004-01-19 | 2005-07-20 | Gumlink A/S | Layered chewing gum tablet |
| DK200401195A (da) * | 2004-08-06 | 2004-08-06 | Gumlink As | Layered chewing gum tablet |
| WO2006063189A2 (en) * | 2004-12-10 | 2006-06-15 | Novartis Ag | Multi-layered chewing gum tablet with quick disintegration layer |
| DK2229156T3 (en) * | 2007-12-20 | 2017-02-06 | Fertin Pharma As | CHEW GUM TABLE AND PROCEDURE FOR DOSING PHARMACEUTICAL ACTIVE INGREDIENTS IN SUCH CHEW GUM TABLE |
| LT2280687T (lt) | 2008-03-26 | 2019-08-26 | Stichting Sanammad | Kramtomosios gumos kompozicijos, apimančios kanabinoidus |
| JP2010252816A (ja) * | 2010-08-23 | 2010-11-11 | Gumlink As | 圧縮チューインガムタブレット |
| US20140083878A1 (en) * | 2012-09-21 | 2014-03-27 | Mylan Inc. | Transdermal drug delivery device |
| HK1247084A1 (zh) * | 2015-02-02 | 2018-09-21 | APIRx Pharmaceuticals, LLC | 大麻素和糖醇复合物，制备和使用的方法 |
| CA3000862C (en) * | 2015-10-07 | 2023-03-14 | Medcan Pharma A/S | Medical chewing gum comprising cannabinoid |
| EP3463287B1 (en) * | 2016-05-27 | 2026-01-28 | NordicCan A/S | Powdered composition comprising a complex between a cannabinoid and a basic ion exchange resin |
| WO2018102296A1 (en) * | 2016-11-29 | 2018-06-07 | Axim Biotechnologies, Inc. | Chewing gum composition comprising cannabinoids and gabapentin |
| US20170265494A1 (en) * | 2017-06-05 | 2017-09-21 | International Consolidated Companies, Inc. | Chewing gum including nanozome encapsulated cannabidiol |
-
2019
- 2019-10-10 ES ES19805887T patent/ES2970150T3/es active Active
- 2019-10-10 EP EP19805887.7A patent/EP3876744B1/en active Active
- 2019-10-10 EP EP23211191.4A patent/EP4306105A3/en active Pending
- 2019-10-10 WO PCT/DK2019/050308 patent/WO2020177819A1/en not_active Ceased
- 2019-10-10 BR BR112021012489-6A patent/BR112021012489A2/pt not_active Application Discontinuation
- 2019-10-10 AU AU2019432306A patent/AU2019432306B2/en active Active
- 2019-10-10 MX MX2021008938A patent/MX2021008938A/es unknown
- 2019-10-10 JP JP2021547498A patent/JP7601779B2/ja active Active
- 2019-10-10 CN CN201980090171.9A patent/CN113423279A/zh active Pending
-
2021
- 2021-06-29 ZA ZA2021/04509A patent/ZA202104509B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US11590230B2 (en) | Compositions of therapeutic substances, methods and uses thereof | |
| RU2018107713A (ru) | Композиции на основе флавоноидов и способы применения | |
| US20120121730A1 (en) | Pharmaceutical and nutraceutical compositions for treating respiratory disease and associated phlegm | |
| US11234944B2 (en) | Pharmaceutical compositions comprising a statin and a cannabinoid and uses thereof | |
| WO2009082459A2 (en) | Anti-aging composition containing resveratrol and method of administration | |
| WO2019234743A1 (en) | Anti-inflammatory synergistic compositions comprising cannabinoids and licorice | |
| CA3181940A1 (en) | Uses and formulations of cannabinoids | |
| JP2025182116A (ja) | 高親油性生理活性物質の放出制御製剤 | |
| US12491174B2 (en) | Omega-3 compositions and methods relating thereto | |
| Sardarabadi et al. | Nanophytomedicine: A promising practical approach in phytotherapy | |
| US12569529B2 (en) | Natural combination products and methods for regulation of kidney and excretory system function | |
| WO2007144080A2 (de) | Antidepressiva-kombinations-wafer | |
| US20240390397A1 (en) | Cannabinoid formulation for oral administration | |
| US20060189543A1 (en) | Compositions and methods for the treatment of leukemia | |
| CN111494394A (zh) | 骨化三醇在治疗或预防高原病的药物组合物中的应用 | |
| JPWO2020177819A5 (https=) | ||
| JPWO2020177818A5 (https=) | ||
| CN109464450B (zh) | 一种预防和治疗脑卒中的药物及其制备方法 | |
| JP2012229242A (ja) | アントラキノン系薬剤含有下剤医薬組成物 | |
| EP4058002A1 (en) | Chewing gum containing synergistic medicinal compounds | |
| CN111543638B (zh) | 一种具有辅助降血糖功效的海参多糖产品及其制备方法 | |
| CN109432082B (zh) | 一种防治化学性肝损伤的药物组合物 | |
| CN115843245A (zh) | 大麻素的用途和制剂 | |
| JP2007112795A (ja) | アントラキノン系薬剤含有下剤医薬組成物 | |
| US20240139100A1 (en) | Transmucosal delivery of tocotrienols |